EU funding readiness: what reviewers look for in your pathway to impact

 EU funding proposals are often lost not because the idea is weak, but because the pathway is unclear. Reviewers want to see a credible journey from your current maturity to a higher maturity, with proof steps that match the workplan and resources.

In practice, strong proposals tend to communicate five things clearly:

1. Where you are now: current TRL and what is already proven.
   
   
2. What uncertainty remains: the specific risks that block adoption or scale.
   
   
3. What you will prove in the project: evidence goals aligned to TRL progression.
   
   
4. How you will prove it: methods, datasets, pilots, stakeholder involvement, and measurable outcomes.
   
   
5. Why it matters: impact logic tied to real health system needs and adoption mechanisms.
   
   

A common weakness is “validation language” without validation content. Saying “we will validate the solution” is not enough. Reviewers want to know what evidence will exist at the end, and what decision it enables.

A second weakness is misaligned budgeting. If your workplan suggests clinical proving but the resources look like software development only, reviewers will assume the plan is not feasible.

Worthmed® supports EU funding readiness by helping teams structure maturity narratives, define realistic evidence plans, and align proof activities with work packages and measurable outputs.